KH

Kuang He

Vice President at Novo Holdings

Copenhagen, Capital Region of Denmark

Overview 

Kuang He is a Biotech VC currently serving as Vice President at Novo Holdings, with prior experience at Sofinnova Partners and a background in Biomedical Innovation & Entrepreneurship. He holds a Ph.D. from Indiana University Bloomington and has worked in various roles at esteemed organizations like ExxonMobil and Procter & Gamble. Highlights of Kuang He's career include serving as a Board Observer at Stealth NewCo and his current position as Vice President at Novo Holdings, where he focuses on investing in digital health, health IT, and other sectors within the biotech industry.

Work Experience 

  • Vice President

    2024 - Current

    - Focused on company creations in the therapeutics space (pre-Seed, Seed financings) and occasional direct Series A-B investments - Drive strategic decision making in near-clinic and clinical-stage companies in the portfolio

  • Board Observer

    2025

  • Board Member

    2025

  • Board Observer

    2024

  • Board Observer

    2024

  • Analyst/Associate

    2019 - 2023

    Focused on equity investments in clinical-stage pharmaceutical and medical devices companies in the CrossOver Fund. Led due diligence on: - Mainstay Medical $108m Series A in 2021 - CytoImmune $27m Series A in 2021 - Artios Pharma $153m Series C in 2021 - Amolyt Pharma $138m Series C in 2023 (acquired by AstraZeneca for $1.05b in 2024)

  • Clinical Research Fellow - Hematology/Oncology

    2017 - 2019

  • Microbiologist

    2014 - 2016

  • Summer Intern - Beauty & Grooming

    2011 - 2011

Noxell Corporation manufactures and markets perfumes, colognes, cosmetic, and toiletry products under CoverGirl brand name.

Articles About Kuang

Relevant Websites